PRTN3 and rheumatoid arthritis: In contrast, ACPAs are typically detected in 70–80% of RA patient sera, and are more disease-specific for RA compared to RFs, although ACPA seropositivity of 9% has been reported in other rheumatic diseases than RA [12,13,14,15,16].